110 related articles for article (PubMed ID: 8168223)
1. [Effects of different treatments on plasma t-PA and PAI activity in AMI].
Zhu G
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Oct; 15(5):374-9. PubMed ID: 8168223
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females.
Koh SC; Yuen R; Viegas OA; Chua SE; Ng BL; Sen DK; Ratnam SS
Thromb Haemost; 1991 Nov; 66(5):581-5. PubMed ID: 1803623
[TBL] [Abstract][Full Text] [Related]
3. [The evaluation of thrombolytic effect of snake venom antithrombus enzyme in treatment of acute myocardial infarction].
Zhang SY; Jin L; Yan XW
Zhonghua Nei Ke Za Zhi; 1994 Apr; 33(4):244-7. PubMed ID: 7956563
[TBL] [Abstract][Full Text] [Related]
4. Changes in plasma levels of tissue plasminogen activator and its inhibitor in aged myocardial infarction patients.
Chen HZ; Jia HY; Song HY; Wang JY
Chin Med J (Engl); 1990 Jul; 103(7):541-5. PubMed ID: 2119970
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis.
Tran-Thang C; Fasel-Felley J; Pralong G; Hofstetter JR; Bachmann F; Kruithof EK
Thromb Haemost; 1989 Sep; 62(2):651-3. PubMed ID: 2510345
[TBL] [Abstract][Full Text] [Related]
6. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
[TBL] [Abstract][Full Text] [Related]
7. [The kinetics of plasma coagulation fibrinolysis levels in acute myocardial infarction before and after treatment with intravenous urokinase].
Bai XJ; Chen CX; He YL
Zhonghua Nei Ke Za Zhi; 1991 Apr; 30(4):205-7, 253. PubMed ID: 1908371
[TBL] [Abstract][Full Text] [Related]
8. The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator.
Huber K; Beckmann R; Rauscha F; Probst P; Kaindl F; Binder BR
Z Kardiol; 1993; 82 Suppl 2():195-200. PubMed ID: 8328203
[TBL] [Abstract][Full Text] [Related]
9. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
[TBL] [Abstract][Full Text] [Related]
10. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
11. [Dynamic changes in fibrinolytic system in patients with acute myocardial infarction].
Zhang SY; Jin L; Zhu GJ
Zhonghua Nei Ke Za Zhi; 1991 Dec; 30(12):743-5, 789. PubMed ID: 1815876
[TBL] [Abstract][Full Text] [Related]
12. Influence of cardiac output on peak t-PA plasma levels in patients receiving thrombolytic therapy with recombinant tissue-type plasminogen activator--correlation with patency rate.
Huber K; Beckmann R; Probst P; Rauscha F; Kaindl F; Binder BR
Thromb Haemost; 1993 Jan; 69(1):45-9. PubMed ID: 8446938
[TBL] [Abstract][Full Text] [Related]
13. The acute effect of insulin on tissue plasminogen activator and plasminogen activator inhibitor in man.
Landin K; Tengborn L; Chmielewska J; von Schenck H; Smith U
Thromb Haemost; 1991 Feb; 65(2):130-3. PubMed ID: 1905068
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor activity in bacterial infection.
Páramo JA; Fernández Diaz FJ; Rocha E
Thromb Haemost; 1988 Jun; 59(3):451-4. PubMed ID: 3142082
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-I levels in acute myocardial infarction.
Yamada S; Yamada R; Ishii A; Ashikawa K; Kawamitsu H; Fujita K
J Cardiol; 1996 Apr; 27(4):171-8. PubMed ID: 8642503
[TBL] [Abstract][Full Text] [Related]
16. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
17. [t-PA activity, antigen and PAI-1 antigen levels in blood obtained from the patients with cerebral infarction].
Yamada S; Yamada R; Ishii A; Ashikawa K; Nakamura M; Sasamata M; Watanabe S
Rinsho Byori; 1990 Jul; 38(7):819-24. PubMed ID: 2119465
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
19. Effects of moderate alcohol consumption on platelet function, tissue-type plasminogen activator and plasminogen activator inhibitor.
Veenstra J; Kluft C; Ockhuizen TH; vd Pol H; Wedel M; Schaafsma G
Thromb Haemost; 1990 Jun; 63(3):345-8. PubMed ID: 2119523
[TBL] [Abstract][Full Text] [Related]
20. Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein.
Cugno M; Cicardi M; Colucci M; Bisiani G; Merlini PA; Spinola A; Paonessa R; Agostoni A
Thromb Haemost; 1996 Aug; 76(2):234-8. PubMed ID: 8865537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
